This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk
Molecular Neurodegeneration Open Access 16 January 2012
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Blacker, D. et al. Nature Genet. 19, 357– 360 (1998).
Matthijs, G. & Maryen, P. Nucleic Acids Res. 19 , 5102 (1991).
Pericak-Vance, M.A. et al. JAMA 278, 1237–1241 (1997).
Rogaeva, E. et al. JAMA 280, 614–618 (1998).
Spielman, R.S. & Ewens, W.J. Am. J. Hum. Genet. 62 , 450–458 (1998).
Kaplan, N.L., Martin, E.R. & Weir, B.S. Am. J. Hum. Genet. 60, 691– 702 (1997).
Scott, W.K. et al. JAMA 281, 513–514 (1999).
Padgett, R.A., Grabowski, P.J., Konarska, M.M., Seiler, S. & Sharp, P.A. Annu. Rev. Biochem. 55, 1119–1150 (1986).
Van Leuven, F., Marynen, P., Cassiman, J.-J. & Van den Berghe, H. J. Immunol. Methods 111, 39–49 (1988).
Van Leuven, F., Torrekens, S., Overbergh, L., de Strooper, B. & van den Berghe, H. Eur. J. Biochem. 210, 319–327 (1992).
Laurell, C.B. & Jeppson, J.-O. in The Plasma Proteins (ed. Putnam, F.W.) 229–264 (Academic Press, New York, 1975).
Korovaitseva, G.I. et al. Ann. Neurol. (in press).
Yu, G. et al. J. Biol. Chem. 273, 16470– 16475 (1998).
McKhann, G. et al. Neurology 34, 939– 945 (1984).
Farrer, L.A., et al. Ann. Neurol. 44, 808– 811 (1998).
Breslow, N.E. & Day, N.E. Statistical Methods in Cancer Research. Vol 1. The Analysis of Case-control Studies. (International Agency for Research on Cancer) (IARC scientific publication, Lyon, France, 1980).
Acknowledgements
Supported by: federal grants AG09029 (L.A.F.), NS31153 (M.A.P.-V., J.L.H.) and AG05128 (A.D.R., A.S., D.S.); a LEAD award for excellence in Alzheimer disease (A.D.R.); a T.L. Temple award (M.A.P.-V.) and grants RG2-96044 (M.A.P.-V.) and RG2-96051 (J.L.H.) from the Alzheimer Association; the Medical Research Council of Canada, Canadian Genetic Diseases Network, Alzheimer Association of Ontario, Howard Hughes Medical Research Foundation, EJLB Foundation (P.H.St.G.-H.); FWO-Vlaanderen, NFWO-Lotto, VLAB/IWT, the 4th Framework EEC-Biotechnology program and by the Rooms-fund (F.V.L.); Peterborough Burgess Fellowship (E.A.R.); Uehara Memorial Foundation and Japan Society for the Promotion of Science (T.K.); and a fellowship from NIH grant T32-AG00115 (S.P.).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rogaeva, E., Premkumar, S., Grubber, J. et al. An α-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease. Nat Genet 22, 19–21 (1999). https://doi.org/10.1038/8729
Issue Date:
DOI: https://doi.org/10.1038/8729
This article is cited by
-
Influence of Alpha-2-Macroglobulin 5 bp I/D and Ile1000Val Polymorphisms on the Susceptibility of Alzheimer’s disease: A Systematic Review and Meta-analysis of 52 Studies
Cell Biochemistry and Biophysics (2014)
-
Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk
Molecular Neurodegeneration (2012)
-
Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests
Molecular Psychiatry (2009)
-
Further examination of the candidate genes in chromosome 12p13 locus for late-onset Alzheimer disease
Neurogenetics (2008)
-
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Nature Genetics (2007)